Annual Total Long Term Liabilities
$3.77 M
-$468.00 K-11.05%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual total long term liabilities is currently $3.77 million, with the most recent change of -$468.00 thousand (-11.05%) on 31 December 2023. During the last 3 years, it has fallen by -$6.22 million (-62.27%). ACRV annual total long term liabilities is now -97.05% below its all-time high of $127.48 million, reached on 31 December 2021.ACRV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$2.97 M
-$270.00 K-8.33%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly total long term liabilities is currently $2.97 million, with the most recent change of -$270.00 thousand (-8.33%) on 30 September 2024. Over the past year, it has dropped by -$671.00 thousand (-18.41%). ACRV quarterly long term liabilities is now -97.67% below its all-time high of $127.48 million, reached on 01 December 2021.ACRV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.1% | -18.4% |
| 3 y3 years | -62.3% | -97.7% |
| 5 y5 years | - | - |
ACRV Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -97.0% | at low | -97.7% | at low |
| 5 y | 5 years | -97.0% | at low | -97.7% | at low |
| alltime | all time | -97.0% | at low | -97.7% | at low |
Acrivon Therapeutics Common Stock Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.97 M(-8.3%) |
| June 2024 | - | $3.24 M(-7.4%) |
| Mar 2024 | - | $3.50 M(-7.1%) |
| Dec 2023 | $3.77 M | $3.77 M(+3.4%) |
| Sept 2023 | - | $3.64 M(-5.3%) |
| June 2023 | - | $3.85 M(-4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $4.05 M(-4.5%) |
| Dec 2022 | $4.24 M(-96.7%) | $4.24 M(-96.7%) |
| Sept 2022 | - | $126.94 M(-0.1%) |
| June 2022 | - | $127.12 M(-0.3%) |
| Dec 2021 | $127.48 M(+1176.7%) | - |
| Dec 2021 | - | $127.48 M |
| Dec 2020 | $9.98 M | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual total long term liabilities?
- What is the all time high annual total long term liabilities for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual total long term liabilities year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly long term liabilities year-on-year change?
What is Acrivon Therapeutics Common Stock annual total long term liabilities?
The current annual total long term liabilities of ACRV is $3.77 M
What is the all time high annual total long term liabilities for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual total long term liabilities is $127.48 M
What is Acrivon Therapeutics Common Stock annual total long term liabilities year-on-year change?
Over the past year, ACRV annual total long term liabilities has changed by -$468.00 K (-11.05%)
What is Acrivon Therapeutics Common Stock quarterly total long term liabilities?
The current quarterly long term liabilities of ACRV is $2.97 M
What is the all time high quarterly long term liabilities for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly total long term liabilities is $127.48 M
What is Acrivon Therapeutics Common Stock quarterly long term liabilities year-on-year change?
Over the past year, ACRV quarterly total long term liabilities has changed by -$671.00 K (-18.41%)